-
Tirofiban, sold
under the
brand name Aggrastat, is an
antiplatelet medication. It
belongs to a
class of
antiplatelets named glycoprotein IIb/IIIa inhibitors...
-
inhibitors exist:
abciximab (abcixifiban) (ReoPro)
eptifibatide (Integrilin)
tirofiban (Aggrastat)
roxifiban orbofiban Glycoprotein IIb/IIIa
inhibitors are frequently...
-
receptor is a
target of
several drugs including abciximab, eptifibatide, and
tirofiban. Once
platelets are activated,
granules secrete clotting mediators, including...
-
inhibitors (intravenous use only)
Abciximab (ReoPro)
Eptifibatide (Integrilin)
Tirofiban (Aggrastat)
Irreversible cyclooxygenase inhibitors Aspirin Triflusal (Disgren)...
- hirudin. Yet
another drug
produced from E.
carinatus venom is
Aggrastat (
Tirofiban). As of
November 2016,
antivenom is
currently being developed by the Costa...
-
Desmopressin Factor VIIa
Thrombopoietin mimetics Abciximab Eptifibatide Tirofiban Others: oprelvekin, romiplostim, eltrombopag,
argatroban Platelet transfusion...
-
medications clopidogrel, cefoperazone,
valproic acid, cefotetan, eptifibatide,
tirofiban, and ticlopidine.
Anticoagulants and
thrombolytic medications also increase...
-
acceptance after the
specific antibody abciximab and the non-peptide
tirofiban entered the
global market.
Eptifibatide is used to
reduce the risk of...
-
Iloprost B01AC13
Abciximab B01AC15
Aloxiprin B01AC16
Eptifibatide B01AC17
Tirofiban B01AC18
Triflusal B01AC19
Beraprost B01AC21
Treprostinil B01AC22 Prasugrel...
-
Califf RM, de
Lemos JA,
Gibson CM, et al. (July 2005). "Tenecteplase and
tirofiban in ST-segment
elevation acute myocardial infarction:
results of a randomized...
